Alfa Fasengas

Recent publications · Crossref

5 total works indexed

1. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants

   · 2021 · cited 2,971x

2. Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma

   · 2018 · cited 1,999x

3. Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study

   · 2020 · cited 1,390x

4. Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma

   · 2022 · cited 1,166x

5. Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial

   · 2022 · cited 1,011x

via Crossref · CC0